Background Psoriasis is an inflammatory disease associated with multiple comorbidities.
Biomarkers for the assessment of psoriasis, its associated comorbidities, and the therapeutic …

Psoriasis is a chronic inflammatory skin disease induced by multifactorial causes and is
characterized by bothersome, scaly reddish plaques, especially on frequently chafed body …

Objectives This study was conducted to assess the utility of neutrophil‐to‐lymphocyte ratio
(NLR) and platelet‐to‐lymphocyte ratio (PLR) in predicting radiographic sacroiliitis and …

Atopic dermatitis (AD) is a chronic inflammatory skin disease with severe itch. The
eosinophil-to-lymphocyte ratio (ELR), neutrophil-to-lymphocyte ratio (NLR), monocyte-to …

Background: Psoriasis is a chronic immune-mediated skin disease in which systemic
inflammation plays an important role in its pathogenesis. In recent years, the neutrophil-to …

We performed a retrospective and observational study of patients with psoriasis. The aim of
this study was to define the laboratory indicators reflecting the treatment response to tumor …

Background Inflammation in the form of elevated high-sensitivity c-reactive protein (hs-CRP)
has been shown to be critical in the development of atherothrombosis. Psoriasis, a chronic …

Background: Tralokinumab, a monoclonal anti-IL-13 antibody, is approved for treating atopic
dermatitis (AD). Real-world data on its effectiveness and safety are limited. Objective: To …

Background: TNF-α inhibitors are effective biological agents for treating psoriasis, but the
treatment responses differ across patients. This study aimed to identify genetic biomarkers of …

Objectives: Systemic inflammation has an important role in psoriasis, which is a chronic
disease with an increasing prevalence and is associated with comorbidity. Our aim is to …